Loading stock data…
$12.86-0.34 (-2.58%)
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America.
The Chemours Company in the Basic Materials sector is trading at $12.86 with a market capitalization of $2.4B. Wall Street consensus targets $16.90 (10 analysts), implying a +31.4% move over the next 12 months. The stock is currently near its 52-week low of $10.44, remaining 29.6% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.59B↑ | $1.38B↑ | $1.33B↓ | $1.50B↓ | $1.61B |
| Gross Profit | $286.00M↑ | $212.00M↑ | $156.00M↓ | $233.00M↓ | $278.00M |
| Operating Income | -$210.00M↓ | $39.00M↑ | -$5.00M↓ | $93.00M↑ | -$174.00M |
| Net Income | -$274.00M↓ | -$29.00M↑ | -$61.00M↓ | $60.00M↑ | -$380.00M |
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advan...